Clinical utility of secukinumab in moderate-to-severe scalp psoriasis: evidence to date

Clinical utility of secukinumab in moderate-to-severe scalp psoriasis: evidence to date

Dario Kivelevitch,1 Sima Amin,2 Alan Menter11Baylor University Medical Center, Dallas, TX, USA; 2Texas A&M College of Medicine, Bryan, TX, USAAbstract: Psoriasis is an immune-mediated inflammatory dermatosis commonly affecting the scalp and fringes of the face, neck and ears. It may be diffi...

Full description

Bibliographic Details
Main Authors: Kivelevitch D, Amin S, Menter A
Format: Article
Language:English
Published: Dove Medical Press 2019-04-01
Series:Clinical, Cosmetic and Investigational Dermatology
Subjects:
Secukinumab
psoriasis
scalp
therapy
Online Access:https://www.dovepress.com/clinical-utility-of-secukinumab-in-moderate-to-severe-scalp-psoriasis--peer-reviewed-article-CCID

Internet

https://www.dovepress.com/clinical-utility-of-secukinumab-in-moderate-to-severe-scalp-psoriasis--peer-reviewed-article-CCID

Similar Items